Pathophysiology of Canine Cystine Urolithiasis
Cystine urolithiasis stems from a proximal renal tubular defect that involves the inadequate reabsorption of the amino acid cystine. Normally, the kidneys filter and then reclaim cystine; however, in affected dogs, this process is impaired. This leads to cystinuria, where high concentrations of cystine reach the lower urinary tract. When the urine pH is acidic, cystine becomes highly insoluble, precipitating out of solution to form crystals and, eventually, uroliths. This condition is distinct from Calcium Oxalate Urolithiasis, as the crystals are unique in their chemical composition and formation triggers.
Genetic Predisposition and Inheritance
Most cases of cystine urolithiasis are inherited as an autosomal recessive trait. However, in certain breeds, the expression can be sex-linked or involve complex polygenic factors. Understanding the lineage of a dog is critical, as breeders should avoid pairing individuals known to carry the defective gene. Unlike Malnutrition, this is not caused by dietary intake, though diet plays a central role in management.
Clinical Manifestations and Diagnostic Indicators
Dogs with cystinuria may present with various symptoms depending on the size and location of the stones. Common indicators include:
- Dysuria (straining to urinate)
- Pollakiuria (frequent small amounts of urine)
- Hematuria (blood in the urine)
- Stranguria (painful urination)
- Anuria (complete inability to pass urine
- emergency)
Imaging and Laboratory Protocols
Veterinarians typically start with a urinalysis to check for characteristic hexagonal crystals. Radiography and ultrasonography are used to visualize the stones; however, cystine stones are often less radiopaque than other types, such as Calcium Phosphate Urolithiasis, making ultrasound the gold standard for identification.
Medical and Surgical Management Strategies
Treatment focuses on two fronts: dissolving existing stones and preventing new ones. Pharmacological agents such as D-penicillamine or 2-mercaptopropionylglycine (tiopronin) are frequently prescribed to increase the solubility of cystine in the urine. When stones are too large for dissolution or are causing an obstruction, surgical intervention such as a cystotomy is required.
Long-Term Monitoring and Prevention
Prevention centers on dilution and alkalinity. Increasing water intake is the most effective way to decrease the saturation of cystine in the urine. Additionally, diets specifically formulated to be low in protein or supplemented to raise urinary pH are essential. Owners should avoid high-protein treats, as they may inadvertently mirror aspects of Dietary Hypersensitivity while exacerbating the cystine load.
